Methods Used to Investigate the Digestive Vacuole

Overview

Journal Front Cell Infect Microbiol

Specialties Cell Biology
Infectious Diseases
Microbiology

Date 2022 Jan 31

PMID 35096663

Authors

Rebecca C S Edgar

Natalie A Counihan

Sheena McGowan

Tania F de Koning-Ward

Affiliations

Soon will be listed here.

Abstract

malaria remains a global health problem as parasites continue to develop resistance to all antimalarials in use. Infection causes clinical symptoms during the intra-erythrocytic stage of the lifecycle where the parasite infects and replicates within red blood cells (RBC). During this stage, digests the main constituent of the RBC, hemoglobin, in a specialized acidic compartment termed the digestive vacuole (DV), a process essential for survival. Many therapeutics in use target one or multiple aspects of the DV, with chloroquine and its derivatives, as well as artemisinin, having mechanisms of action within this organelle. In order to better understand how current therapeutics and those under development target DV processes, techniques used to investigate the DV are paramount. This review outlines the involvement of the DV in therapeutics currently in use and focuses on the range of techniques that are currently utilized to study this organelle including microscopy, biochemical analysis, genetic approaches and metabolomic studies. Importantly, continued development and application of these techniques will aid in our understanding of the DV and in the development of new therapeutics or therapeutic partners for the future.

Citing Articles

Are Species Pathogenic? Nutrient Uptake and Approaches to Diagnose Infections.

Salti M, Sam-Yellowe T Pathogens. 2024; 13(7).

PMID: 39057826 PMC: 11279546. DOI: 10.3390/pathogens13070600.

The Digestive Vacuole of the Malaria Parasite: A Specialized Lysosome.

Wiser M Pathogens. 2024; 13(3).

PMID: 38535526 PMC: 10974218. DOI: 10.3390/pathogens13030182.

From Myzocytosis to Cytostomal Nutrient Uptake and Transport by Intracellular Species.

Sam-Yellowe T Pathogens. 2023; 12(8).

PMID: 37623996 PMC: 10458102. DOI: 10.3390/pathogens12081036.

Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual blood stages.

Okombo J, Mok S, Qahash T, Yeo T, Bath J, Orchard L PLoS Pathog. 2022; 18(10):e1010926.

PMID: 36306287 PMC: 9645663. DOI: 10.1371/journal.ppat.1010926.

References

Wicht K, Mok S, Fidock D . Molecular Mechanisms of Drug Resistance in Malaria. Annu Rev Microbiol. 2020; 74:431-454. PMC: 8130186. DOI: 10.1146/annurev-micro-020518-115546. View

Ehlgen F, Pham J, De Koning-Ward T, Cowman A, Ralph S . Investigation of the Plasmodium falciparum food vacuole through inducible expression of the chloroquine resistance transporter (PfCRT). PLoS One. 2012; 7(6):e38781. PMC: 3374814. DOI: 10.1371/journal.pone.0038781. View

Malcolm T, Swiderska K, Hayes B, Webb C, Drag M, Drinkwater N . Mapping the substrate specificity of the Plasmodium M1 and M17 aminopeptidases. Biochem J. 2021; 478(13):2697-2713. PMC: 8286833. DOI: 10.1042/BCJ20210172. View

Ncokazi K, Egan T . A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds. Anal Biochem. 2005; 338(2):306-19. DOI: 10.1016/j.ab.2004.11.022. View

Lewis I, Wacker M, Olszewski K, Cobbold S, Baska K, Tan A . Metabolic QTL analysis links chloroquine resistance in Plasmodium falciparum to impaired hemoglobin catabolism. PLoS Genet. 2014; 10(1):e1004085. PMC: 3879234. DOI: 10.1371/journal.pgen.1004085. View

Elliott D, McIntosh M, Hosgood 3rd H, Chen S, Zhang G, Baevova P . Four distinct pathways of hemoglobin uptake in the malaria parasite Plasmodium falciparum. Proc Natl Acad Sci U S A. 2008; 105(7):2463-8. PMC: 2268159. DOI: 10.1073/pnas.0711067105. View

Gruring C, Heiber A, Kruse F, Ungefehr J, Gilberger T, Spielmann T . Development and host cell modifications of Plasmodium falciparum blood stages in four dimensions. Nat Commun. 2011; 2:165. DOI: 10.1038/ncomms1169. View

Tong J, Chandramohanadas R, Tan K . High-Content Screening of the Medicines for Malaria Venture Pathogen Box for Plasmodium falciparum Digestive Vacuole-Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery. Antimicrob Agents Chemother. 2018; 62(3). PMC: 5826141. DOI: 10.1128/AAC.02031-17. View

Combrinck J, Fong K, Gibhard L, Smith P, Wright D, Egan T . Optimization of a multi-well colorimetric assay to determine haem species in Plasmodium falciparum in the presence of anti-malarials. Malar J. 2015; 14:253. PMC: 4484700. DOI: 10.1186/s12936-015-0729-9. View

10.

Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C . Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016; 16(3):357-65. PMC: 4792715. DOI: 10.1016/S1473-3099(15)00487-9. View

11.

Hamilton W, Amato R, van der Pluijm R, Jacob C, Quang H, Thuy-Nhien N . Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study. Lancet Infect Dis. 2019; 19(9):943-951. PMC: 6715858. DOI: 10.1016/S1473-3099(19)30392-5. View

12.

Xie S, Dogovski C, Hanssen E, Chiu F, Yang T, Crespo M . Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins. J Cell Sci. 2015; 129(2):406-16. PMC: 4732288. DOI: 10.1242/jcs.178830. View

13.

De Niz M, Burda P, Kaiser G, Del Portillo H, Spielmann T, Frischknecht F . Progress in imaging methods: insights gained into Plasmodium biology. Nat Rev Microbiol. 2016; 15(1):37-54. DOI: 10.1038/nrmicro.2016.158. View

14.

Giannangelo C, Siddiqui G, De Paoli A, Anderson B, Edgington-Mitchell L, Charman S . System-wide biochemical analysis reveals ozonide antimalarials initially act by disrupting Plasmodium falciparum haemoglobin digestion. PLoS Pathog. 2020; 16(6):e1008485. PMC: 7347234. DOI: 10.1371/journal.ppat.1008485. View

15.

Mok S, Stokes B, Gnadig N, Ross L, Yeo T, Amaratunga C . Artemisinin-resistant K13 mutations rewire Plasmodium falciparum's intra-erythrocytic metabolic program to enhance survival. Nat Commun. 2021; 12(1):530. PMC: 7822823. DOI: 10.1038/s41467-020-20805-w. View

16.

Klemba M, Gluzman I, Goldberg D . A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation. J Biol Chem. 2004; 279(41):43000-7. DOI: 10.1074/jbc.M408123200. View

17.

Ross L, Dhingra S, Mok S, Yeo T, Wicht K, Kumpornsin K . Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine. Nat Commun. 2018; 9(1):3314. PMC: 6095916. DOI: 10.1038/s41467-018-05652-0. View

18.

Rocamora F, Zhu L, Liong K, Dondorp A, Miotto O, Mok S . Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites. PLoS Pathog. 2018; 14(3):e1006930. PMC: 5868857. DOI: 10.1371/journal.ppat.1006930. View

19.

Achan J, Talisuna A, Erhart A, Yeka A, Tibenderana J, Baliraine F . Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J. 2011; 10:144. PMC: 3121651. DOI: 10.1186/1475-2875-10-144. View

20.

Wang J, Zhang C, Chia W, Loh C, Li Z, Lee Y . Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum. Nat Commun. 2015; 6:10111. PMC: 4703832. DOI: 10.1038/ncomms10111. View